VarCov Co’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$414K Buy
43,830
+29,924
+215% +$239K 0.2% 182
2026
Q2
$122K Buy
+13,906
New +$105K 0.05% 347
2026
Q1
– Sell
-264,557
Closed -$524K – 497
2025
Q4
$524K Buy
+264,557
New +$599K 0.21% 167

Other funds holding IBRX

VarCov Co's IBRX Position: Q3 2026 in Review

VarCov Co increased its ImmunityBio (IBRX) stake by 215% in Q3 2026, buying an estimated $239K and bringing the position to 43,830 shares worth $414K. The position accounts for 0.2% of the portfolio, ranked #182.

VarCov Co first reported a position in IBRX in Q4 2025 and has held it in 3 quarters since. The position peaked at $524K in Q4 2025. 407 funds tracked by Wall St. Rank hold IBRX as of Q3 2026.

  • VarCov Co held 43,830 shares of ImmunityBio worth $414K as of Q3 2026.
  • VarCov Co bought 29,924 ImmunityBio shares in Q3 2026, an estimated $239K.
  • ImmunityBio made up 0.2% of VarCov Co's portfolio in Q3 2026, its #182 holding.
  • VarCov Co first reported a position in ImmunityBio in Q4 2025 and has held it in 3 quarters since.
  • VarCov Co's ImmunityBio position peaked at $524K in Q4 2025.
  • 407 funds tracked by Wall St. Rank held ImmunityBio as of Q3 2026.

Based on VarCov Co's 13F filing for Q3 2026, filed 16 Nov 2026.